iBio, Inc. (NYSE:IBIO – Get Free Report)’s stock price dropped 7.1% during mid-day trading on Tuesday . The stock traded as low as $2.55 and last traded at $2.60. Approximately 94,416 shares were traded during mid-day trading, a decline of 92% from the average daily volume of 1,128,257 shares. The stock had previously closed at $2.80.
iBio Price Performance
The company has a quick ratio of 3.37, a current ratio of 3.37 and a debt-to-equity ratio of 0.04. The business’s fifty day moving average price is $2.58 and its 200 day moving average price is $2.25.
iBio (NYSE:IBIO – Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported ($0.46) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.46). As a group, analysts anticipate that iBio, Inc. will post -1.74 EPS for the current year.
iBio Company Profile
iBio, Inc, a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel.
Featured Articles
- Five stocks we like better than iBio
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- How to Calculate Options Profits
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Why Invest in 5G? How to Invest in 5G Stocks
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for iBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iBio and related companies with MarketBeat.com's FREE daily email newsletter.
